Sustainability Report

Overview

The report covers ScinoPharm's 2022 sustainability performance, including a GHG inventory of 19,308.02 metric tons CO2e and external verification. It reports 675 employees, three female directors representing 20% of the Board, and a 100% retention rate after unpaid parental leave. The company describes climate-risk governance through the Board and Sustainable Development Committee and sets annual Scope 1 and 2 emissions-intensity and waste-intensity reduction targets of 1-2% from a 2022 base year. PwC provided limited assurance over selected water, renewable electricity, waste, pay-ratio, and parental-leave metrics.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview